Henri Beaufour
French businessman (1965–2025)
From Wikipedia, the free encyclopedia
Henri Beaufour (6 January 1965 – 28 November 2025) was a French billionaire businessman. He was a descendant of Henri Beaufour, founder of the Beaufour laboratories, forerunner of the French biopharmaceutical company Ipsen.[1]
6 January 1965
Henri Beaufour | |
|---|---|
| Born | Henri Pierre Albert Marie Beaufour 6 January 1965 Neuilly-sur-Seine, France |
| Died | 28 November 2025 (aged 60) |
| Alma mater | Georgetown University |
| Occupation | Businessman |
Board member of | Ipsen |
| Parent | Albert Beaufour |
| Relatives | Anne Beaufour (sister) |
Biography
Born on 6 January 1965, in Neuilly-sur-Seine, Henri Beaufour was the son of Albert Beaufour, who died in 2000, and the grandson of Dr. Henri Beaufour, founder of the Ipsen group.[1][2]
He earned a Bachelor of Arts degree from Georgetown University, Washington, D.C.
When Albert Beaufour died in 2000, the 76% of the capital held by the family was divided between the three brothers and sisters. One of the daughters, Véronique Beaufour, sold her share, representing 6% of the capital. Anne and her brother Henri Beaufour thus control 57% of the Ipsen group, and both sit on the board of directors of Ipsen and Mayroy, the Ipsen controlling holding company. Their share in Ipsen was still 52% in 2020.[3]
In 2018, his fortune was estimated at €3 billion.[4][5]
Beaufour died on 28 November 2025.[6]
